Funds Raised

FUNDS RAISEDAMOUNT
BroadRiver III, L.P., New York, NY
Alternative Fixed Income or Private Credit
$876 Million
oversubscribed
Polaris Partners VIII, L.P., Boston, San Francisco, Dublin
Venture/Growth and Healthcare/Technology
$435 Million
oversubscribed
Polaris Partners VIII, L.P., Boston, San Francisco, Dublin
Venture/Growth and Healthcare/Technology
$435 Million
oversubscribed
ForgePoint Capital I, L.P., Palo Alto, CA
Early Stage Venture Capital, Cybersecurity
$300 Million
oversubscribed
BroadRiver II, L.P. and aliated co-investment, New York, NY
Alternative Private Credit
$429 Million
Polaris Partners VII, L.P., Boston, San Francisco, Dublin
Venture/Growth and Healthcare/Technology
$466 Million
oversubscribed
Castlelake III, L.P., Minneapolis, London
Global Distressed Debt Fund
$1.4 Billion
oversubscribed
Castlelake II, L.P. (formerly TPG Credit Strategies II, L.P.), Minneapolis, London
Global Distressed Debt Fund
$997 Million
oversubscribed
Greenpark International Investors IV, L.P., London, UK
Global Private Equity Secondaries Fund and related vehicles
$400 Million
Castelake Aviation II, L.P. (formerly Airline Credit Opportunities II, L.P.), Minneapolis, London
Global Airline Assets and Credit Obligations Opportunities Fund
$605 Million
oversubscribed
Essex Woodlands Health Ventures VIII, L.P., Palo Alto, New York, Houston, London $900 Million
Emerging Companies in Healthcare
$900 Million
Greenpark International Investors III, L.P., London, UK
Global Private Equity Secondaries Fund
€730 Million
oversubscribed
Longreach Capital Partners I, L.P., Hong Kong and Tokyo, Japan
Japanese Buyout Fund, Focus on Strategically Driven Private Equity
$750 Million
oversubscribed
Delta Russia Fund, L.P., Moscow, Russia & New York, NY
Russian Private Equity fund
$119 Million
Greenpark International Investors IV, L.P., London, UK
Global Private Equity Secondaries Fund oversubscribed
€350 Million
oversubscribed
CMEA Ventures VI, L.P., San Francisco, CA
Diversified technology & life sciences venture fund
$300 Million
oversubscribed
Essex Woodlands VI, L.P., Chicago, IL & Houston, TX
Emerging companies within the healthcare industry
$400 Million
oversubscribed
Standard Life Investments – European Strategic Partners II, L.P., Edinburgh, Scotland
European Fund of Funds
€1.09 Billion
oversubscribed
Greenpark International Investors I, L.P., London, UK
Global Private Equity Secondaries Fund
$200 Million
oversubscribed
SpaceVest III, L.P., Reston, VA
Space-related Technology Venture Capital
$83 Million
Solera Partners, L.P., New York, NY
Growth Private Equity
$250 Million
J.P. Morgan Partners (formerly Chase Capital Partners), New York, NY & worldwide
Global Private Equity
$800 Million
Index Ventures I, L.P., Geneva, Switzerland & London, UK
UK/European Venture Capital
$180 Million
oversubscribed
Access Technology Partners, L.P., San Francisco, CA
Late Stage Venture Capital
$320 Million
oversubscribed
CMEA Ventures IV, L.P., San Francisco, CA
Technology-focused Early Stage VC
$180 Million
Eucalyptus Venture Partners, L.P. (now Pitango Venture Capital),
Herzliya, Israel, San Mateo, CA & London, UK – Israeli/U.S. Venture Capital
$55 Million
Primus Venture Partners IV, L.P., Cleveland, OH
Midwest Venture Capital
$165 Million
oversubscribed
SpaceVest II, L.P., Reston, VA
Space-related Technology Venture Capital
$138 Million
oversubscribed
WIIG Communications (Walden International), San Francisco, CA & Asia Pacific
Asian/U.S. Telecom Venture Capital
$150 Million
HealthNet Ventures, L.P. (formerly H&Q Serv*is Ventures), San Francisco, CA
Healthcare Technology Venture Capital, H&Q and Johnson & Johnson joint venture
$35 Million
H&Q Asia Pacific Growth Fund II, L.P., Palo Alto, CA & Asia Pacific
Pan-Asian Private Equity Fund
$278 Million
oversubscribed
Omega Ventures, San Francisco, CA
Robertson Stephens & Co. Late Stage VC
$43 Million
Top